Table 3.
Intraoperative characteristics
| Benign disease group (n = 559) | Malignant disease group | ||||
|---|---|---|---|---|---|
| Overall (n = 1453) | HCC (n = 450) | CLM (n = 546) | Biliary tumours (n = 194) | ||
| Major hepatectomy, n (%) | 299 (53.5%) | 783 (53.9%) | 206 (45.8%)a,b | 284 (52.1%)c | 151 (77.8%) |
| Associated procedures, n (%) | 60 (10.8%)d | 399 (27.5%) | 52 (11.6%)a,b | 141 (25.9%)c | 113 (58.2%) |
| Extrahepatic | 16 (2.7%)d | 205 (14.1%) | 19 (4.2%)a,b | 94 (17.2%)c | 20 (10.3%) |
| Vascular | 9 (1.6%)d | 153 (10.5%) | 34 (7.6%)b | 56 (10.3%)c | 38 (19.6%) |
| Biliary | 40 (7.2%) | 128 (8.8%) | 6 (1.3%)b | 12 (2.2%)c | 103 (53.1%) |
| Operative time, min, mean (range) | 306.55 (30–942)d | 325.18 (20–765) | 285.14 (60–765)a,b | 323.93 (20–690)c | 425 (160–755) |
| Estimated blood loss, ml, mean (range) | 525.21 (0–13000)d | 633 (14–11000) | 681.27 (0–11000) | 607.89 (0–6000) | 698.17 (0–3500) |
| Transfusion, n (%) | 86 (15.3%)d | 330 (22.7%) | 91 (20.2%)b | 114 (20.9%)c | 61 (31.4%) |
| Pedicle clamping, n (%) | 281 (50.3%)d | 930 (64.0%) | 290 (64.4%)b | 347 (63.5%)c | 141 (72.7%) |
| Duration, min, mean (range) | 37.4 (0–212)d | 42.2 (5–150) | 42.8 (1–150) | 40.8 (3–148) | 43.4 (7–140) |
a
Marks a significant difference between HCC and CLM.
b
Marks a significant difference between HCC and biliary tumours.
c
Marks a significant difference between CLM and biliary tumours.
d
Marks a significant difference between the benign and malignant disease groups.
HCC, hepatocellular carcinoma; CLM, colorectal liver metastasis.